Syntheses, structure characterization and dissolution of two novel cocrystals of febuxostat
暂无分享,去创建一个
Xiurong Hu | Xiurong Hu | Yanlei Kang | Jianming Gu | Yanlei Kang | J. Gu | Jian-ming Gu
[1] T. Lu,et al. Phenazopyridine Cocrystal and Salts That Exhibit Enhanced Solubility and Stability , 2012 .
[2] Min-Jeong Lee,et al. Combined anti-solvent and cooling method of manufacturing indomethacin–saccharin (IMC–SAC) co-crystal powders , 2014 .
[3] R. Samanta,et al. New co-crystal and salt form of sulfathiazole with carboxylic acid and amide , 2014, Journal of Chemical Sciences.
[4] H. Brittain. Pharmaceutical cocrystals: the coming wave of new drug substances. , 2013, Journal of pharmaceutical sciences.
[5] W. Schlindwein,et al. Pharmaceutical cocrystals: an overview. , 2011, International journal of pharmaceutics.
[6] E. Tiekink,et al. Crystal and Molecular Structures of the 2:1 Cocrystal of 4-Nitrophenylacetic acid and N,N′-bis(pyridin-3-ylmethyl)oxalamide, and with the Thioxalamide Analogue , 2012, Journal of Chemical Crystallography.
[7] A. Newman,et al. Pharmaceutical Cocrystals and Their Physicochemical Properties , 2009, Crystal growth & design.
[8] I. Imtiaz Ahmed,et al. Synthesis, characterization, solubility and stability studies of hydrate cocrystal of antitubercular Isoniazid with antioxidant and anti-bacterial Protocatechuic acid , 2016 .
[9] G. Desiraju,et al. Unusual co-crystal of isonicotinamide: the structural landscape in crystal engineering , 2012, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[10] D. Xu,et al. A novel l-arginine salt nonlinear optical crystal: l-arginine p-nitrobenzoate monohydrate (LANB) , 2014 .
[11] R. Tan,et al. Cocrystal Hydrate of an Antifungal Drug, Griseofulvin, with Promising Physicochemical Properties , 2012 .
[12] Michael E Ernst,et al. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. , 2009, Clinical therapeutics.
[13] Jianzhong Chen,et al. Naphthalene diimide cocrystals: A facile approach to tune the optical properties , 2015 .
[14] Louis J. Farrugia,et al. WinGX and ORTEP for Windows: an update , 2012 .
[15] William Jones,et al. Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement , 2006 .
[16] M. Caira,et al. Pharmaceutical co-crystals with isonicotinamide – vitamin B3, clofibric acid, and diclofenac – and two isonicotinamide hydrates , 2011 .
[17] A. Nangia,et al. Soluble Cocrystals of the Xanthine Oxidase Inhibitor Febuxostat , 2013 .
[18] Miranda L. Cheney,et al. Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine , 2010 .
[19] M. Sowa,et al. A 1:2 cocrystal of genistein with isonicotinamide: crystal structure and Hirshfeld surface analysis. , 2013, Acta crystallographica. Section C, Crystal structure communications.
[20] S. Velaga,et al. Solubility of carbamazepine, nicotinamide and carbamazepine–nicotinamide cocrystal in ethanol–water mixtures , 2014 .
[21] B. Maddah,et al. A cocrystal of caffeine and dipicolinic acid: synthesis, characterization, X-ray crystallography, and solution studies , 2013, Journal of Structural Chemistry.
[22] R. Tan,et al. Cocrystallization with flufenamic acid: comparison of physicochemical properties of two pharmaceutical cocrystals , 2014 .
[23] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[24] G. Zhu,et al. Three pharmaceuticals cocrystals of adefovir: Syntheses, structures and dissolution study , 2015 .
[25] Dan Boström,et al. Pharmaceutical Cocrystal and Salts of Norfloxacin , 2006 .
[26] Isonicotinamide–2-naphthoic acid (1/1) , 2011, Acta crystallographica. Section E, Structure reports online.